iodixanol has been researched along with Chronic Kidney Diseases in 22 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this clinical trial is to compare iodixanol with iohexol for the incidence of contrast-induced nephropathy in patients with chronic heart failure with reduced ejection fraction who are currently undergoing coronary angiography or angioplasty." | 9.24 | Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty. ( Ge, Z; Li, Y; Shi, P; Song, M; Song, T; Sun, M, 2017) |
| "To determine the incidence of post-contrast acute kidney injury (PC-AKI) and presumed contrast-induced acute kidney injury (CI-AKI) following contrast-enhanced CT (CECT) with intravenous application of a reduced dose of the iso-osmolar contrast agent iodixanol in cancer patients with chronic kidney disease." | 7.96 | Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol. ( Bez, C; Hinterleitner, C; Horger, M; Werner, S, 2020) |
| "The aim of this clinical trial is to compare iodixanol with iohexol for the incidence of contrast-induced nephropathy in patients with chronic heart failure with reduced ejection fraction who are currently undergoing coronary angiography or angioplasty." | 5.24 | Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty. ( Ge, Z; Li, Y; Shi, P; Song, M; Song, T; Sun, M, 2017) |
| "Iodixanol is associated with lower rates of contrast-induced acute kidney injury (CI-AKI)." | 4.02 | Effects of a High Dose of the Contrast Medium Iodixanol on Renal Function in Patients Following Percutaneous Coronary Intervention. ( Azzalini, L; Chen, Z; Huang, L; Jin, J; Li, L; Mao, Q; Song, Y; Tong, W; Xu, Q; Xu, Z; Zhao, N; Zhao, X; Zhou, Y, 2021) |
| "To determine the incidence of post-contrast acute kidney injury (PC-AKI) and presumed contrast-induced acute kidney injury (CI-AKI) following contrast-enhanced CT (CECT) with intravenous application of a reduced dose of the iso-osmolar contrast agent iodixanol in cancer patients with chronic kidney disease." | 3.96 | Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol. ( Bez, C; Hinterleitner, C; Horger, M; Werner, S, 2020) |
| "The relative incidence of long-term adverse effects between low-osmolar contrast media (LOCM) and iso-osmolar contrast media (IOCM) after coronary angiography is still unclear." | 1.43 | Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography. ( Chang, D; Ju, S; Lu, CQ; Tang, A; Wang, YC; Zhang, SJ, 2016) |
| "The odds ratio of acute kidney failure on day 5 was 0." | 1.38 | Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease. ( Ghahramani, N; Lapsiwala, A; Parhizgar, A; Saadulla, L; Spatz, C, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 14 (63.64) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Hami, M | 1 |
| Bigdeli, A | 1 |
| Khameneh Bagheri, R | 1 |
| Rajabi, O | 1 |
| Salehi, M | 1 |
| Zahedi Avval, F | 1 |
| Sharma, A | 1 |
| Kilari, S | 1 |
| Cai, C | 1 |
| Simeon, ML | 1 |
| Misra, S | 1 |
| Werner, S | 1 |
| Bez, C | 1 |
| Hinterleitner, C | 1 |
| Horger, M | 1 |
| Zhao, N | 1 |
| Chen, Z | 1 |
| Zhou, Y | 1 |
| Xu, Q | 1 |
| Xu, Z | 1 |
| Tong, W | 1 |
| Li, L | 1 |
| Mao, Q | 1 |
| Song, Y | 1 |
| Jin, J | 1 |
| Huang, L | 1 |
| Azzalini, L | 1 |
| Zhao, X | 1 |
| Song, T | 1 |
| Song, M | 1 |
| Ge, Z | 1 |
| Li, Y | 1 |
| Shi, P | 1 |
| Sun, M | 1 |
| Kim, J | 1 |
| Male, S | 1 |
| Jagadeesan, BD | 1 |
| Streib, C | 1 |
| Tummala, RP | 1 |
| Kofman, N | 1 |
| Margolis, G | 1 |
| Gal-Oz, A | 1 |
| Letourneau-Shesaf, S | 1 |
| Keren, G | 1 |
| Rozenbaum, Z | 1 |
| Shacham, Y | 1 |
| Chua, HR | 1 |
| Horrigan, M | 1 |
| Mcintosh, E | 1 |
| Bellomo, R | 1 |
| Choi, MJ | 1 |
| Yoon, JW | 1 |
| Han, SJ | 1 |
| Choi, HH | 1 |
| Song, YR | 1 |
| Kim, SG | 1 |
| Oh, JE | 1 |
| Lee, YK | 1 |
| Seo, JW | 1 |
| Kim, HJ | 1 |
| Noh, JW | 1 |
| Koo, JR | 1 |
| Iwama, R | 1 |
| Sato, T | 1 |
| Katayama, M | 1 |
| Shimamura, S | 1 |
| Satoh, H | 1 |
| Ichijo, T | 1 |
| Furuhama, K | 1 |
| Quintavalle, C | 1 |
| Anselmi, CV | 1 |
| De Micco, F | 1 |
| Roscigno, G | 1 |
| Visconti, G | 1 |
| Golia, B | 1 |
| Focaccio, A | 2 |
| Ricciardelli, B | 2 |
| Perna, E | 1 |
| Papa, L | 1 |
| Donnarumma, E | 1 |
| Condorelli, G | 2 |
| Briguori, C | 2 |
| Shema-Didi, L | 1 |
| Kristal, B | 1 |
| Eizenberg, S | 1 |
| Marzuq, N | 1 |
| Sussan, M | 1 |
| Feldman-Idov, Y | 1 |
| Ofir, P | 1 |
| Atar, S | 1 |
| Rezaei, Y | 1 |
| Khademvatani, K | 1 |
| Rahimi, B | 1 |
| Khoshfetrat, M | 1 |
| Arjmand, N | 1 |
| Seyyed-Mohammadzad, MH | 1 |
| Wang, YC | 1 |
| Tang, A | 1 |
| Chang, D | 1 |
| Lu, CQ | 1 |
| Zhang, SJ | 1 |
| Ju, S | 1 |
| Sanon, S | 1 |
| Barsness, GW | 1 |
| Gulati, R | 1 |
| Rudnick, MR | 1 |
| Davidson, C | 1 |
| Laskey, W | 1 |
| Stafford, JL | 1 |
| Sherwin, PF | 1 |
| Spatz, C | 1 |
| Saadulla, L | 1 |
| Lapsiwala, A | 1 |
| Parhizgar, A | 1 |
| Ghahramani, N | 1 |
| Laugharne, MJ | 1 |
| Paravasthu, M | 1 |
| Preston, A | 1 |
| Hill, KO | 1 |
| Sharma, SK | 1 |
| Kini, A | 1 |
| Colombo, A | 1 |
| Airoldi, F | 1 |
| Morici, N | 1 |
| Sangiorgi, GM | 1 |
| Violante, A | 1 |
| Montorfano, M | 1 |
| Carlino, M | 1 |
| Deray, G | 1 |
| Persson, P | 1 |
| Liss, P | 1 |
| Hansell, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Intravenous vs. Oral Hydration to Reduce the Risk of Post-Contrast Acute Kidney Injury After Intravenous Contrast-Enhanced Computed Tomography in Patients With Severe Chronic Kidney Disease (ENRICH): A Randomized Controlled Trial[NCT05283512] | 254 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | |||
| Renal Insufficiency Following Contrast Media Administration Trial II (Remedial II): The RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury[NCT01098032] | Phase 3 | 294 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| [NCT02070679] | Phase 3 | 284 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Antioxidants for Preventing Contrast-Induced Acute Kidney Injury After Coronary Artery Catheterization[NCT03755700] | Phase 3 | 1,000 participants (Anticipated) | Interventional | 2018-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The primary outcome measure will be the rate of development of CI-AKI in the 2 study arms (number of participants). CI-AKI is defined as an increase in the serum creatinine concentration >=0.3 mg/dL from the baseline value at 48 hours after administration of the contrast media or the need for dialysis. (NCT01098032)
Timeframe: at 48 hours following contrast exposure
| Intervention | participants (Number) |
|---|---|
| Systemic Alone Therapy Group | 146 |
| RenalGuard System Group | 146 |
1 review available for iodixanol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Effect of nonionic radiocontrast agents on the occurrence of contrast-induced nephropathy in patients with mild-moderate chronic renal insufficiency: pooled analysis of the randomized trials.
Topics: Contrast Media; Humans; Iohexol; Iopamidol; Kidney Diseases; Randomized Controlled Trials as Topic; | 2005 |
7 trials available for iodixanol and Chronic Kidney Diseases
| Article | Year |
|---|---|
The effect of curcumin in prevention of contrast nephropathy following coronary angiography or angioplasty in CKD patients.
Topics: Acute Kidney Injury; Administration, Oral; Angioplasty; Antioxidants; Contrast Media; Coronary Angio | 2019 |
Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty.
Topics: Adult; Angioplasty, Balloon, Coronary; China; Contrast Media; Coronary Angiography; Double-Blind Met | 2017 |
The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration.
Topics: Acute Kidney Injury; Aged; Contrast Media; Coronary Angiography; Creatinine; Female; Hemofiltration; | 2014 |
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Angiography; Angioplasty; Biomar | 2015 |
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Angiography; Angioplasty; Biomar | 2015 |
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Angiography; Angioplasty; Biomar | 2015 |
Neutrophil Gelatinase-Associated Lipocalin and Contrast-Induced Acute Kidney Injury.
Topics: Acute Kidney Injury; Acute-Phase Proteins; Aged; Aged, 80 and over; Angiography; Angioplasty; Biomar | 2015 |
Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Biomarkers; Contrast Media; Coronary A | 2016 |
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Topics: Acute Kidney Injury; Aged; alpha-Tocopherol; Antioxidants; Biomarkers; Chi-Square Distribution; Cont | 2016 |
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Topics: Acute Kidney Injury; Aged; alpha-Tocopherol; Antioxidants; Biomarkers; Chi-Square Distribution; Cont | 2016 |
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Topics: Acute Kidney Injury; Aged; alpha-Tocopherol; Antioxidants; Biomarkers; Chi-Square Distribution; Cont | 2016 |
Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial.
Topics: Acute Kidney Injury; Aged; alpha-Tocopherol; Antioxidants; Biomarkers; Chi-Square Distribution; Cont | 2016 |
Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.
Topics: Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Diabeti | 2008 |
14 other studies available for iodixanol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Increased fibrotic signaling in a murine model for intra-arterial contrast-induced acute kidney injury.
Topics: Acute Kidney Injury; Animals; Apoptosis; Carotid Arteries; Cell Hypoxia; Cell Proliferation; Collage | 2020 |
Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol.
Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Incidence; Male | 2020 |
Effects of a High Dose of the Contrast Medium Iodixanol on Renal Function in Patients Following Percutaneous Coronary Intervention.
Topics: Acute Kidney Injury; Aged; Contrast Media; Female; Glomerular Filtration Rate; Humans; Incidence; Ma | 2021 |
Safety of cerebral angiography and neuroendovascular therapy in patients with chronic kidney disease.
Topics: Aged; Cerebral Angiography; Contrast Media; Endovascular Procedures; Female; Glomerular Filtration R | 2018 |
Long-term renal outcomes and mortality following renal injury among myocardial infarction patients treated by primary percutaneous intervention.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Comorbidity; Contrast Media; Creatinine; Disease Progr | 2019 |
Extended renal outcomes with use of iodixanol versus iohexol after coronary angiography.
Topics: Acute Kidney Injury; Age Distribution; Aged; Cohort Studies; Contrast Media; Coronary Angiography; F | 2014 |
Relationship of glomerular filtration rate based on serum iodixanol clearance to IRIS staging in cats with chronic kidney disease.
Topics: Animals; Case-Control Studies; Cat Diseases; Cats; Contrast Media; Creatinine; Female; Glomerular Fi | 2015 |
Long-Term Adverse Effects of Low-Osmolar Compared With Iso-Osmolar Contrast Media After Coronary Angiography.
Topics: Aged; Cause of Death; China; Contrast Media; Coronary Angiography; Female; Heart Failure; Humans; In | 2016 |
A Novel Technique to Reduce Contrast Exposure During Subclavian Interventions.
Topics: Acute Kidney Injury; Aged; Angiography, Digital Subtraction; Angioplasty, Balloon; Arterial Occlusiv | 2017 |
Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
Topics: Acute Kidney Injury; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme In | 2012 |
CT pulmonary angiography in elderly patients: outcomes in patients aged >85 years.
Topics: Age Factors; Aged, 80 and over; Contrast Media; Female; Humans; Iohexol; Male; Patient Safety; Pulmo | 2013 |
Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Contrast Media; Female; Fluid Therapy; Humans; Iohexol; K | 2005 |
Visipaque (iodixanol) and hexabrix (ioxaglate) in renal insufficiency.
Topics: Acute Kidney Injury; Contrast Media; Coronary Angiography; Coronary Disease; Humans; Incidence; Ioxa | 2007 |
Evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in coronary angiography.
Topics: Acute Kidney Injury; Contrast Media; Coronary Angiography; Coronary Disease; Humans; Ioxaglic Acid; | 2007 |